Inspire Medical Systems Operating Income 2017-2024 | INSP

Inspire Medical Systems operating income from 2017 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Inspire Medical Systems Annual Operating Income
(Millions of US $)
2024 $36
2023 $-40
2022 $-48
2021 $-40
2020 $-56
2019 $-35
2018 $-20
2017 $-16
2016 $-17
Inspire Medical Systems Quarterly Operating Income
(Millions of US $)
2024-12-31 $32
2024-09-30 $14
2024-06-30 $5
2024-03-31 $-15
2023-12-31 $9
2023-09-30 $-13
2023-06-30 $-17
2023-03-31 $-19
2022-12-31 $0
2022-09-30 $-17
2022-06-30 $-14
2022-03-31 $-16
2021-12-31 $-2
2021-09-30 $-10
2021-06-30 $-13
2021-03-31 $-16
2020-12-31 $-7
2020-09-30 $-10
2020-06-30 $-23
2020-03-31 $-16
2019-12-31 $-9
2019-09-30 $-9
2019-06-30 $-8
2019-03-31 $-9
2018-12-31 $-5
2018-09-30 $-5
2018-06-30 $-6
2018-03-31 $-5
2017-12-31 $-4
2017-09-30 $-4
2017-06-30 $-4
2017-03-31 $-4
2016-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $4.461B $0.803B
Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.567B 53.27
Hims & Hers Health (HIMS) United States $11.630B 120.84
Tempus AI (TEM) United States $10.569B 0.00
IRhythm Technologies (IRTC) United States $4.396B 0.00
Privia Health (PRVA) United States $3.035B 208.50
Enovis (ENOV) United States $1.887B 10.53
Clover Health Investments (CLOV) United States $1.793B 0.00
Schrodinger (SDGR) United States $1.746B 0.00
Phreesia (PHR) United States $1.506B 0.00
Azenta (AZTA) United States $1.223B 56.96
Omnicell (OMCL) United States $1.208B 21.31
10x Genomics (TXG) United States $1.073B 0.00
Fulgent Genetics (FLGT) United States $0.600B 0.00
Butterfly Network (BFLY) United States $0.551B 0.00
Talkspace (TALK) United States $0.509B 151.00
Veradigm (MDRX) United States $0.466B 0.00
Standard BioTools (LAB) United States $0.406B 0.00
TruBridge (TBRG) United States $0.371B 827.00
Claritev (CTEV) United States $0.351B 0.00
Health Catalyst (HCAT) United States $0.290B 0.00
Nyxoah SA (NYXH) Belgium $0.215B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.195B 0.00
EUDA Health Holdings (EUDA) Singapore $0.144B 0.00
Pulmonx (LUNG) United States $0.136B 0.00
American Well (AMWL) United States $0.107B 0.00
Retrieve Medical Holdings (RMHI) United States $0.089B 0.00
MDxHealth SA (MDXH) Belgium $0.088B 0.00
CareCloud (CCLD) United States $0.081B 3.07
111 (YI) China $0.068B 0.00
P3 Health Partners (PIII) United States $0.063B 0.00
HeartBeam (BEAT) United States $0.060B 0.00
Outset Medical (OM) United States $0.055B 0.00
Zepp Health (ZEPP) Netherlands $0.038B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Precipio (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00